E-Newsletter - December 2020
Alliance Translational Research
Alliance Imaging committee Expands to Include
New Subcommittee on Theranostics
The Alliance Imaging Committee has recently received approval to expand by forming a new Subcommittee on Theranostics in support of therapeutic radionuclide studies. The Imaging Committee is now seeking suggestions and nominations for a Subcommittee Chair and for members of this subcommittee who will also join the Imaging Committee. Michael Knopp, MD, PhD, of IROC Ohio, will chair the search process, along with Michael Morris, MD, and Jeffrey Meyerhardt, MD, MPH, as search committee members. Suggestions should be sent to Committee Chair Larry Schwartz, MD (lschwartz@columbia.edu) and Dr. Knopp (knopp.16@osu.edu).
Additionally, the Imaging Committee is expanding its general membership as its portfolio has increased. For Radiologists, Imaging Scientists, Physicists, Oncologists, and others who may be interested in joining the Imaging Committee, please contact Drs. Schwartz and Knopp.
For other articles in this issue of the Alliance E-News newsletter, see below.
- Message From the Group Chair - Monica M. Bertagnolli, MD
-
Alliance Investigators Work to Bring Practice-Changing Treatment Through Registration Trials
Alliance A011801 - HER2+ Breast Cancer
Alliance A021502 - Colon Cancer
Alliance A021602 - Neuroendocrine Tumors
Alliance A041701 - Acute Myeloid Leukemia -
Alliance Announcements
Alliance Appoints New Alliance Health Disparities Committee Chair - Lucile L. Adams-Campbell
Alliance Imaging Committee Expands to Include New Subcommittee on Theranostics
Recap: Alliance/AFT Abstracts at 2020 SABCS Meeting
Recap: Alliance/AFT Abstracts at 2020 ASH Meeting -
New Trials Alert
Alliance A191901 - Support for Patients with Breast Cancer
Alliance A021804 - Advanced Neuroendocrine Cancer
Alliance A031901 - Metastatic Urothelial Carcinoma
Alliance A071702 - Somatically Hypermutated Recurrent Glioblastoma - Closed to Accrual: Alliance A011502 (ABC Trial)
-
Alliance in the News
Precision Treatment Advances Improve Survival in Women with Aggressive HER2+ Breast Cancer
Black Race an Independent Predicator of Poor Survival Among Young Adults with AML
Ohio State Creates Clara D. Bloomfield Center for Leukemia Outcomes Research
American Cancer Society Announces New Members and Officers of Board of Directors